Chimovits Erez
Director, 10% Owner
1 filing on record here, covering BRVE. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-11
| Convert | BRVE | Braveheart Bio, Inc. | |
| Buy | BRVE | Braveheart Bio, Inc. | $30,000,006 |
| Buy | BRVE | Braveheart Bio, Inc. | $4,919,994 |
| Convert | BRVE | Braveheart Bio, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.